Guanhao Biotech Co.,Ltd. (SHE:300238)
China flag China · Delayed Price · Currency is CNY
16.38
+0.07 (0.43%)
Jul 4, 2025, 2:45 PM CST

Guanhao Biotech Statistics

Total Valuation

Guanhao Biotech has a market cap or net worth of CNY 4.35 billion. The enterprise value is 4.29 billion.

Market Cap 4.35B
Enterprise Value 4.29B

Important Dates

The next estimated earnings date is Thursday, August 28, 2025.

Earnings Date Aug 28, 2025
Ex-Dividend Date n/a

Share Statistics

Guanhao Biotech has 265.16 million shares outstanding. The number of shares has increased by 1.12% in one year.

Current Share Class 265.16M
Shares Outstanding 265.16M
Shares Change (YoY) +1.12%
Shares Change (QoQ) -5.28%
Owned by Insiders (%) 1.88%
Owned by Institutions (%) 6.19%
Float 199.76M

Valuation Ratios

The trailing PE ratio is 155.42.

PE Ratio 155.42
Forward PE n/a
PS Ratio 11.43
PB Ratio 8.91
P/TBV Ratio 9.08
P/FCF Ratio n/a
P/OCF Ratio 80.95
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 71.64, with an EV/FCF ratio of -361.74.

EV / Earnings 153.83
EV / Sales 11.27
EV / EBITDA 71.64
EV / EBIT 127.81
EV / FCF -361.74

Financial Position

The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.27.

Current Ratio 1.94
Quick Ratio 1.25
Debt / Equity 0.27
Debt / EBITDA 2.17
Debt / FCF -10.96
Interest Coverage 17.73

Financial Efficiency

Return on equity (ROE) is 3.30% and return on invested capital (ROIC) is 3.60%.

Return on Equity (ROE) 3.30%
Return on Assets (ROA) 2.88%
Return on Invested Capital (ROIC) 3.60%
Return on Capital Employed (ROCE) 5.43%
Revenue Per Employee 718,564
Profits Per Employee 52,625
Employee Count 530
Asset Turnover 0.52
Inventory Turnover 1.13

Taxes

In the past 12 months, Guanhao Biotech has paid 10.78 million in taxes.

Income Tax 10.78M
Effective Tax Rate 40.48%

Stock Price Statistics

The stock price has increased by +81.80% in the last 52 weeks. The beta is 0.85, so Guanhao Biotech's price volatility has been lower than the market average.

Beta (5Y) 0.85
52-Week Price Change +81.80%
50-Day Moving Average 14.70
200-Day Moving Average 13.18
Relative Strength Index (RSI) 57.45
Average Volume (20 Days) 23,388,236

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Guanhao Biotech had revenue of CNY 380.84 million and earned 27.89 million in profits. Earnings per share was 0.11.

Revenue 380.84M
Gross Profit 300.32M
Operating Income 33.57M
Pretax Income 26.65M
Net Income 27.89M
EBITDA 53.62M
EBIT 33.57M
Earnings Per Share (EPS) 0.11
Full Income Statement

Balance Sheet

The company has 121.85 million in cash and 130.04 million in debt, giving a net cash position of -8.19 million or -0.03 per share.

Cash & Cash Equivalents 121.85M
Total Debt 130.04M
Net Cash -8.19M
Net Cash Per Share -0.03
Equity (Book Value) 488.31M
Book Value Per Share 2.10
Working Capital 136.48M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 53.76 million and capital expenditures -65.62 million, giving a free cash flow of -11.86 million.

Operating Cash Flow 53.76M
Capital Expenditures -65.62M
Free Cash Flow -11.86M
FCF Per Share -0.04
Full Cash Flow Statement

Margins

Gross margin is 78.86%, with operating and profit margins of 8.81% and 7.32%.

Gross Margin 78.86%
Operating Margin 8.81%
Pretax Margin 7.00%
Profit Margin 7.32%
EBITDA Margin 14.08%
EBIT Margin 8.81%
FCF Margin n/a

Dividends & Yields

Guanhao Biotech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 10.81%
Buyback Yield -1.12%
Shareholder Yield n/a
Earnings Yield 0.64%
FCF Yield -0.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on April 16, 2015. It was a forward split with a ratio of 2.

Last Split Date Apr 16, 2015
Split Type Forward
Split Ratio 2

Scores

Guanhao Biotech has an Altman Z-Score of 6.92 and a Piotroski F-Score of 6.

Altman Z-Score 6.92
Piotroski F-Score 6